Stephens downgraded Paragon 28 (FNA) to Equal Weight from Overweight with a $13 price target after Zimmer Biomet (ZBH) agreed to acquire the ...

Barclays downgraded Ameren (AEE) to Equal Weight from Overweight with a price target of $95, up from $88. The shares trade at an 11% ...

The fund owned 9,700 shares of the company’s stock after buying an additional 1,096 shares during the quarter. Mutual Advisors LLC’s holdings in Direxion NASDAQ-100 Equal Weighted Index Shares ...

Wells Fargo Maintains Equal-Weight on NextEra Energy Partners, Lowers Price Target to $13 Analyst ratings measure the expected performance of a stock during a given time period. Analysts and ...

The topline results from the Phase 1b/2a clinical trial showed that patients treated with Amycretin achieved a body weight loss of ... bullish on the healthcare stock. According to S&P Global ...

Analysis of the study data, assuming all people adhered to treatment, revealed that patients starting with a mean baseline weight of 92.7 kg experienced an estimated weight loss of 9.7% on 1.25mg ...

The Invesco S&P 500 Equal Weight Materials ETF (RSPM) made its debut on 11/01/2006, and is a smart beta exchange traded fund that provides broad exposure to the Materials ETFs category of the market.

Novo Nordisk (NVO) stock jumped 12% in pre-market trading Friday after it released promising results of an early-stage weight loss drug trial. The Danish pharmaceutical giant announced Friday that ...

The highest price of DSP Nifty 50 Equal Weight ETF stock is ₹351.28 in the last 52-week. What is the share price of DSP Nifty 50 Equal Weight ETF (EQUAL50ADD) today on NSE? As on Jan 27 ...

“The goal of our study would be to prove that, by combining the Allurion Balloon and Allurion Virtual Care Suite with GLP-1 therapy, patients can lose significant weight while increasing muscle ...

The highest price of Nifty 50 Equal Weight stock is 33,780.95 in the last 52-week. DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from ...

Novo Nordisk's U.S.-listed shares are surging 9% Friday morning after the Danish drugmaker reported early stage results for its amycretin weight-loss ... Novo Nordisk Stock Had Been Trending ...